ENTX
Entera BioFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
ENTX vs peer average
32/100
ENTX vs. peer average (F vs. D)
Grade spread
A 1 · C 1 · D 5 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ATOS is the first available peer comparator.
Loose same-sector, similar-market-cap biotech comparator from the packet; useful only for financing sensitivity and binary clinical-event volatility, not as a direct osteoporosis or oral-peptide peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ENTX
Entera Bio
ATOS
Atossa Therapeutics
Grade
F
D
Momentum
94
2
Value
41
59
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ATOS
ENTX / ATOS
Grade Position
Below peers
ENTX vs. peer average (F vs. D)
32/100
Momentum
94
ENTXValue
41
ATOSSentiment
0
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ENTX
ATOS is the first peer returned for this comparison set.